Design and Synthesis of 2-(4-Bromophenyl)Quinoline-4-Carbohydrazide Derivatives via Molecular Hybridization as Novel Microbial DNA-Gyrase Inhibitors

被引:19
作者
Abd El-Lateef, Hany M. [5 ,6 ]
Elmaaty, Ayman Abo [1 ]
Abdel Ghany, Lina M. A. [2 ]
Abdel-Aziz, Mohamed S. [3 ]
Zaki, Islam [7 ]
Ryad, Noha [4 ]
机构
[1] Port Said Univ, Fac Pharm, Med Chem Dept, Port Said 42526, Egypt
[2] Misr Univ Sci & Technol, Coll Pharmaceut Sci & Drug Mfg, Pharmaceut Chem Dept, 6th October City 3236101, Egypt
[3] Natl Res Ctr, Biotechnol Res Inst, Microbial Chem Dept, Cairo 12622, Egypt
[4] Misr Univ Sci & Technol, Coll Pharmaceut Sci & Drug Mfg, Pharmaceut Organ Chem Dept, Giza 3236101, Egypt
[5] King Faisal Univ, Coll Sci, Dept Chem, Al Hasa 31982, Saudi Arabia
[6] Sohag Univ, Fac Sci, Dept Chem, Sohag 82524, Egypt
[7] Port Said Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Port Said 42526, Egypt
来源
ACS OMEGA | 2023年 / 8卷 / 20期
关键词
IN-VITRO; ABSORPTION; RESISTANCE; IIA;
D O I
10.1021/acsomega.3c01156
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Microbial DNA gyraseis regarded as an outstanding microbial target.Hence, 15 new quinoline derivatives (5-14) were designed and synthesized. The antimicrobial activity of theafforded compounds was pursued via in vitro approaches.The investigated compounds displayed eligible MIC values, particularlyagainst G-positive Staphylococcus aureus species. Consequently, an S. aureus DNA gyrase supercoiling assay was performed, using ciprofloxacinas a reference control. Obviously, compounds 6b and 10 unveiled IC50 values of 33.64 and 8.45 & mu;M,respectively. Alongside, ciprofloxacin exhibited an IC50 value of 3.80 & mu;M. Furthermore, a significant docking bindingscore was encountered by compound 6b (-7.73 kcal/mol),surpassing ciprofloxacin (-7.29 kcal/mol). Additionally, bothcompounds 6b and 10 revealed high GIT absorptionwithout passing the blood brain barrier. Finally, the conducted structure-activityrelationship study assured the usefulness of the hydrazine moietyas a molecular hybrid for activity either in cyclic or opened form.
引用
收藏
页码:17948 / 17965
页数:18
相关论文
共 68 条
  • [1] Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization
    Abo Elmaaty, Ayman
    Hamed, Mohammed I. A.
    Ismail, Muhammad I.
    B. Elkaeed, Eslam
    S. Abulkhair, Hamada
    Khattab, Muhammad
    Al-Karmalawy, Ahmed A.
    [J]. MOLECULES, 2021, 26 (12):
  • [2] Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors
    Al-Wahaibi, Lamya H.
    Amer, Amer A.
    Marzouk, Adel A.
    Gomaa, Hesham A. M.
    Youssif, Bahaa G. M.
    Abdelhamid, Antar A.
    [J]. PHARMACEUTICALS, 2021, 14 (05)
  • [3] Design, synthesis, antimicrobial activity and molecular docking studies of some novel di-substituted sulfonylquinoxaline derivatives
    Ammar, Yousry A.
    Farag, Awatef A.
    Ali, Abeer M.
    Ragab, Ahmed
    Askar, Ahmed A.
    Elsisi, Doaa M.
    Belal, Amany
    [J]. BIOORGANIC CHEMISTRY, 2020, 104
  • [4] Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies
    Ammar, Yousry A.
    Farag, Awatef A.
    Ali, Abeer M.
    Hessein, Sadia A.
    Askar, Ahmed A.
    Fayed, Eman A.
    Elsisi, Doaa M.
    Ragab, Ahmed
    [J]. BIOORGANIC CHEMISTRY, 2020, 99
  • [5] [Anonymous], 2016, Molecular Operating Environment (MOE). 08
  • [6] N6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5′-N-ethylearboxamido-adenosines:: The first example of adenosine-related structures with potent agonist activity at the human A2B adenosine receptor
    Baraldi, Pier Giovanni
    Preti, Delia
    Tabrizi, Mojgan Aghazadeh
    Fruttarolo, Francesca
    Saponaroa, Giulia
    Baraldi, Stefania
    Romagnoli, Romeo
    Moorman, Allan R.
    Gessi, Stefania
    Varani, Katia
    Borea, Pier Andrea
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (07) : 2514 - 2527
  • [7] Type IIA topoisomerase inhibition by a new class of antibacterial agents
    Bax, Benjamin D.
    Chan, Pan F.
    Eggleston, Drake S.
    Fosberry, Andrew
    Gentry, Daniel R.
    Gorrec, Fabrice
    Giordano, Ilaria
    Hann, Michael M.
    Hennessy, Alan
    Hibbs, Martin
    Huang, Jianzhong
    Jones, Emma
    Jones, Jo
    Brown, Kristin Koretke
    Lewis, Ceri J.
    May, Earl W.
    Saunders, Martin R.
    Singh, Onkar
    Spitzfaden, Claus E.
    Shen, Carol
    Shillings, Anthony
    Theobald, Andrew J.
    Wohlkonig, Alexandre
    Pearson, Neil D.
    Gwynn, Michael N.
    [J]. NATURE, 2010, 466 (7309) : 935 - U51
  • [8] Molecular mechanisms of antibiotic resistance
    Blair, Jessica M. A.
    Webber, Mark A.
    Baylay, Alison J.
    Ogbolu, David O.
    Piddock, Laura J. V.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2015, 13 (01) : 42 - 51
  • [9] Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
    Collin, Frederic
    Karkare, Shantanu
    Maxwell, Anthony
    [J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2011, 92 (03) : 479 - 497
  • [10] SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
    Daina, Antoine
    Michielin, Olivier
    Zoete, Vincent
    [J]. SCIENTIFIC REPORTS, 2017, 7